Sources Sought_ Eletrophoresis.docx

Sources Sought Notice Sources Sought Notice

GENERAL INFORMATION

SET-ASIDE

CONTRACTING OFFICE ADDRESS

Department of Veterans Affairs Network Contracting Office 6 100 Emancipation Drive Hampton VA 23667

POINT OF CONTACT*

Contract Specialist NaTasha Hawkins Natasha.Hawkins@va.gov

PLACE OF PERFORMANCE

1201 Broad Rock Blvd

Richmond Virginia

ADDITIONAL INFORMATION

DESCRIPTION

The Department of Veterans Affairs, Network Contracting Office (NCO) 6 on behalf of Richmond VAMC is conducting Market Research through this Sources Sought notice to help determine the availability of qualified Businesses, capable of providing a Capillary Electrophoresis that meets the following:

REQUIREMENTS

Capillary instrumentation must provide the following test menu and sufficient throughput capacity to meet Richmond VAMC testing volume:

Serum Protein Electrophoresis (SPE) – 40 tests/day at 60 tests/hour Urine Protein Electrophoresis (UPE) – 12 tests/day at 60 tests/hour Serum and Urine Immunotyping by immunosubtraction - 9 tests/hour Hemoglobin electrophoresis - 40 test/hour Hb A1c - 30 tests/hour Capillary instrumentation must have the following features and specifications:

Gel based system must have the following features:

EQUIPMENT:

The Capillary Analyzer(s) must include the following capabilities:

1. Must be fully automated from primary tube to result.

1. Must have automated primary tube sampling.

1. Method must be capillary electrophoresis.

1. On board bar code reader for full traceability with positive sample and rack ID.

1. Must have ability to highlight and alert user to previous patient history within the software.

1. Must have unlimited database storage.

1. Must have ability to recall past result and overlay on current pattern for comparison purposes.

1. Software must have multi-tasking capability using windows menus.

1. Must have capability to link patient results across multiple assays.

1. Must have networking capabilities to link multiple databases together.

1. Must have on-board quality control including statistic program with Levy-Jennings graphing.

1. Must have minimal reagent and control preparation.

1. Must have no sample pre-treatment requirements for serum.

1. Methodology must provide an adequate reportable range.

1. Methods will demonstrate accuracy and precision with analyte appropriate coefficients of variation.

1. Must have proven bi-directional interface capability, including demographic query and data transmission, with VISTA software through Data Innovations and host query capability. Must be operational to satisfaction within 60 days of installation.

1. Equipment must support multiple barcode formats that may be enabled concurrently.

1. Equipment must accept, at a minimum, a 10-character specimen identifier (20-character flexibility is preferred) that is alphanumeric (letters and numbers).

1. Equipment must be able to store and retransmit records in case of interface outage.

1. Software for operation of the system must be windows driven, user friendly, with point and click icons for easy operation (desirable).

1. Equipment and reagents must be of highest quality to satisfy proficiency testing standards of the College of American Pathologists (CAP) and/or The Joint Commission (TJC).

1. Have minimal maintenance required.

The Gel Electrophoresis System must include the following capabilities:

a. Must have ability to store the complete gel images in separate electronic files for future use.

b. Must be semi- automated instrument with ability to add front end automation to minimize preanalytical steps.

c. Must have ability to highlight previous patient history within the software.

d. Must have unlimited database storage.

e. Must have ability to recall past result and overlay on current pattern for comparison purposes.

f. Software must have multi-tasking capability using windows menus.

g. Must have capability to link patient results across multiple assays.

h. Must have networking capabilities to link multiple databases together.

i. Must have quality control statistic program such as Levy-Jennings within the software.

j. Must have minimal reagent and control preparation.

k. Methodology must provide an adequate reportable range.

l. Methods will demonstrate accuracy and precision with analyte appropriate coefficients of variation.

m. Must have bi-directional interface capability, including demographic query and data transmission, with VISTA software through Data Innovations and host query capability. Must be operational to satisfaction within 60 days of installation.

n. The Contractor must provide a validated method, by capillary or gel electrophoresis, to mitigate interference from therapeutic monoclonal antibodies (e.g., anti-CD38 agents such as daratumumab and isatuximab)

o. System must have onboard touch screen.

p. System must have onboard reagent (stain) counter.

q. Equipment must be able to store and retransmit records in case of interface outage.

r. Software for operation of the system must be windows driven, user friendly, with point and click icons for easy operation (desirable).

s. Equipment and reagents must be of highest quality to satisfy proficiency testing standards of the College of American Pathologists (CAP) and/or The Joint Commission (TJC).

t. Have minimal maintenance required.

All respondents shall indicate/provide the following:

•Whether or not they are small business manufacturers of the products they wish to offer, or if they are a reseller of a small business manufacturer.

•Is your company interested in providing a Federal Supply Schedule (FSS) quote or Open Market (indicate FSS contract #)?

•Identify any other companies owned (wholly or in-part) by the owners of this business who provide goods or services under the same or a related NAICS codes.

•Identify any other companies owned (wholly or in-part) by the owners of this business who provide goods or services that are registered under the same or a related NAICS code with the Center for Veterans Enterprise (CVE); Provide the certification type (SDVOSB/VOSB), Federal Identification Number, and state of incorporation for each.

•Whether or not your company has an active SAM registration and the companies Unique Entity Identifier.

•A copy of its capabilities statement.

Failure to provide the above information may result in the potential offeror being considered incapable of meeting the VA’s needs.

If the contractor can provide the above items, the contractor shall provide a letter from the manufacturer stating they are an authorized distributor/licenser of their products. Failure to submit an authorized distributor letter shall result in the product(s) potentially offered to be considered “grey market” and shall not be considered technically acceptable.

The capability statements received from this market research are for planning purposes only and will assist the Government in planning its acquisition strategy. This is strictly market research, and the Government will not entertain questions concerning this market research. The Government will not assume any costs incurred by the contractor in the preparation of responses. All responses shall be submitted in writing no later than October 08, 2026, at 5:00 PM EST to the attention of: Natasha.Hawkins@va.gov Please title the subject line for all responses as: Capillary Electrophoresis.

Sources Sought Notice